Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
110.52
+0.73 (0.66%)
Sep 30, 2024, 4:00 PM EDT - Market closed
Cardinal Health Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 118.08, with a low estimate of 101 and a high estimate of 137. The average target predicts an increase of 6.84% from the current stock price of 110.52.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CAH stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 8 | 8 | 8 | 6 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy Maintains $115 → $125 | Strong Buy | Maintains | $115 → $125 | +13.10% | Sep 11, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $111 → $123 | Hold | Maintains | $111 → $123 | +11.29% | Aug 21, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $115 → $119 | Hold | Maintains | $115 → $119 | +7.67% | Aug 16, 2024 |
| UBS | UBS | Strong Buy Maintains $120 → $125 | Strong Buy | Maintains | $120 → $125 | +13.10% | Aug 15, 2024 |
| Wells Fargo | Wells Fargo | Sell Maintains $95 → $101 | Sell | Maintains | $95 → $101 | -8.61% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
218.70B
from 226.83B
Decreased by -3.58%
Revenue Next Year
236.82B
from 218.70B
Increased by 8.28%
EPS This Year
7.70
from 3.45
Increased by 123.33%
EPS Next Year
8.52
from 7.70
Increased by 10.60%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 229.4B | 258.1B | 283.0B | |
| Avg | 218.7B | 236.8B | 253.5B | |
| Low | 208.0B | 225.5B | 239.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.1% | 18.0% | 19.5% | |
| Avg | -3.6% | 8.3% | 7.1% | |
| Low | -8.3% | 3.1% | 1.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 8.06 | 9.14 | 10.03 | |
| Avg | 7.70 | 8.52 | 9.33 | |
| Low | 7.43 | 7.70 | 8.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 133.7% | 18.6% | 17.7% | |
| Avg | 123.3% | 10.6% | 9.4% | |
| Low | 115.3% | -0.0% | -2.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.